Reporting owner · Q3 2026 · CIK 1878824

McCombe William D.: insider trades.

McCombe William D. reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Transactions
6
Purchases (P)
0
Sales (S)
0
Companies
1
Name as filed
McCombe William D.

Companies

CompanyRelationshipTransactions
Cytek Biosciences, Inc. (CTKB)Officer · Chief Financial Officer6

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-18Cytek Biosciences, Inc.M13,051—128,437Form 4
2026-08-18Cytek Biosciences, Inc.F5,401$4.67134,693Form 4
2026-08-18Cytek Biosciences, Inc.M16,049—140,094Form 4
2026-08-18Cytek Biosciences, Inc.F4,392$4.67124,045Form 4
2026-08-18Cytek Biosciences, Inc.M6,320—117,497Form 4
2026-08-18Cytek Biosciences, Inc.F2,111$4.67115,386Form 4

Questions

What stock did McCombe William D. buy or sell?

McCombe William D. reported 6 non-derivative transactions on 1 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 1 company.

Is McCombe William D. the same person as other filers with this name?

This page covers SEC CIK 1878824 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/mccombe-william-d-1878824.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.